AgomAb Therapeutics NV
€6.50
3
-€0.15-2.26% 07:55 Today
Statistics
Day High
6.5
Day Low
6.5
52W High
13.4
52W Low
6.5
Volume
-
Avg. Volume
-
Mkt Cap
320.11M
P/E Ratio
46.16
Dividend Yield
-
Dividend
-
Dividends
0%Dividend Yield
Apr 2016
€2.22
May 2015
€2.23
May 2014
€1.81
May 2013
€1.71
May 2012
€1.74
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow M5E.F. It's not an investment recommendation.
Allianz
2
ALV.XETRA
Mercedes-Benz Group
2
MBG.XETRA
Basf
2
BAS.XETRA
Muenchener Rueckversicherungs-Gesellschaft
2
MUV2.F
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Show More
CEO
Tim Knotnerus
Employees
62
Country
Sweden
ISIN
US00860C1027
WKN
000A421MA
Listings
0 Comments
Share your thoughts
FAQs
What is AgomAb Therapeutics NV stock price today?▼
The current price of M5E.F is €6.50 EUR — it has decreased by -2.26% in the past 24 hours. Watch AgomAb Therapeutics NV stock price performance more closely on the chart.
What is AgomAb Therapeutics NV stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange AgomAb Therapeutics NV stocks are traded under the ticker M5E.F.
What is AgomAb Therapeutics NV market cap?▼
Today AgomAb Therapeutics NV has the market capitalization of 320.11M
Does AgomAb Therapeutics NV pay dividends?▼
Yes, M5E.F dividends are paid annual. The last dividend per share was 2.22 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does AgomAb Therapeutics NV have?▼
As of November 2, 2026, the company has 62 employees.
In which sector is AgomAb Therapeutics NV located?▼
AgomAb Therapeutics NV operates in the Health & Wellness sector.
When did AgomAb Therapeutics NV complete a stock split?▼
AgomAb Therapeutics NV has not had any recent stock splits.
Where is AgomAb Therapeutics NV headquartered?▼
AgomAb Therapeutics NV is headquartered in Antwerp, Sweden.